Back to top
more

Zimmer Biomet Holdings, Inc. (ZBH)

(Delayed Data from NYSE)

$124.08 USD

124.08
654,749

+1.06 (0.86%)

Updated Jul 18, 2019 03:58 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.80%
17.93%
9.58%
5.18%
2.03%
10.63%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

B Value | C Growth | C Momentum | B VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Zimmer Biomet Grows Internationally Despite Pricing Pressure

Zimmer Biomet (ZBH) witnesses strength in the EMEA and APAC regions as well as in the Spine & CMF business.

CERN BRKR PEN ZBH

Zacks Equity Research

Why Is Zimmer (ZBH) Down 8.2% Since Last Earnings Report?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZBH

Urmimala Biswas

Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates

While sales in Americas remains dull, Zimmer Biomet (ZBH) is witnessing strength in the Asia Pacific and EMEA regions.

ABT SYK ZBH CNMD

Zacks Equity Research

Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?

With Zimmer Biomet (ZBH) focusing solely on this restructuring initiative, chances are slim for the company to post promising growth performances across its operating segments.

ZBH NSTG EOLS ACB

Zacks Equity Research

Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline

Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZBH

Zacks Equity Research

Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings

With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.

VEEV ITGR HOLX ZBH

Zacks Equity Research

Zimmer Biomet Solid on Global Prospects Despite Price Pressure

Zimmer Biomet (ZBH) has been working to strengthen foothold in emerging markets. However, the company has been facing continued pricing pressure.

VEEV HOLX ITGR ZBH

Zacks Equity Research

RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio

RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.

ISRG RTIX SYK ZBH

Zacks Equity Research

Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%

Zimmer Biomet (ZBH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ZBH APYX

Zacks Equity Research

Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Revenues Top

Zimmer Biomet (ZBH) sees strength in the Asia Pacific and EMEA regions as well as in the Spine & CMF business in Q4.

VAR ANGO ZBH CNMD

Zacks Equity Research

Zimmer Biomet (ZBH) Meets Q4 Earnings Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of 0.00% and 0.54%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

ZBH

Zacks Equity Research

ZBH & IDXX Q4 Earnings on Feb 1: Here are the Key Predictions

The global medical device space is passing through a rewarding phase for a considerable period of time in terms of research and development (R&D) plus regulatory progress.

IDXX ZBH

Zacks Equity Research

Medical Products Industry Outlook: Plenty of Upside Left

The growing adoption of AI, Medical Mechatronics & Robotics has lent the Medical Products industry a competitive edge in the broader medical market.

SYK VIVO ZBH

Zacks Equity Research

Can Zimmer Biomet (ZBH) Grow on Hip Business in Q4 Earnings?

Within Hip business, we expect Zimmer Biomet (ZBH) to experience a strong uptick in the Asia-Pacific region.

NSTG DXCM ZBH MGNX

Zacks Equity Research

Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings Growth

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZBH

Zacks Equity Research

Is Zimmer Biomet (ZBH) a Great Stock for Value Investors?

Let's see if Zimmer Biomet (ZBH) stock is a good choice for value-oriented investors right now from multiple angles.

ZBH

Zacks Equity Research

Zimmer Biomet (ZBH) Thrives on New Projects, APAC Growth

Zimmer Biomet (ZBH) is performing well on the back of its two largest commercial projects, namely the Persona Revision system and the Rosa robotics knee application.

VEEV ITGR SRDX ZBH

Zacks Equity Research

Zimmer Biomet Rides on New Operational Plan Amid Several Woes

In order to tackle several near-term concerns, Zimmer Biomet (ZBH) of late begins to review its 2018 operating plan to clearly define its go-forward strategies in a number of thrust areas.

VEEV ITGR ZBH SRDX

Zacks Equity Research

Should Value Investors Pick Zimmer Biomet (ZBH) Stock?

Is Zimmer Biomet (ZBH) a great pick from the value investor's perspective right now? Read on to know more.

ZBH

Zacks Equity Research

Zimmer (ZBH) Down 7.7% Since Last Earnings Report: Can It Rebound?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZBH

Zacks Equity Research

The Zacks Analyst Blog Highlights: Comcast, ConocoPhillips, Delta Air Lines, ServiceNow and Zimmer Biomet

The Zacks Analyst Blog Highlights: Comcast, ConocoPhillips, Delta Air Lines, ServiceNow and Zimmer Biomet

DAL NOW CMCSA ZBH COP

Mark Vickery

Top Research Reports for Comcast, ConocoPhillips & Delta Air Lines

Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), ConocoPhillips (COP), and Delta Air Lines (DAL).

ZBH XEL NOW DAL COP CMCSA

Zacks Equity Research

Zimmer Biomet (ZBH) Q3 Earnings Top Estimates, Margins Down

We are encouraged by Zimmer Biomet's (ZBH) consistent effort in product renovation through research and development.

MASI ZBH BAX AMED

Zacks Equity Research

Zimmer Biomet (ZBH) Q3 Earnings and Revenues Beat Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of 1.87% and 0.11%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

ZBH

Zacks Equity Research

What's in Store for Zimmer Biomet (ZBH) This Earnings Season?

Focusing on areas like quality correction, supply recovery and product introductions, Zimmer Biomet (ZBH) is expected to see robust top-line numbers at S.E.T. arm in Q3.

TMO ZBH BAX MYGN